Retraction
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer
Paper Information
Record ID:
52217
Author(s):
Publication Date:
March 16, 2019
Retraction Date:
February 23, 2024
(1.7 year years ago)
Subjects:
Country:
🇮🇹 ItalyArticle Type:
Publisher:
American Chemical Society (ACS)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1021/acs.jmedchem.4c00381Citations (63)
63
Total Citations11
Post-Retraction(17.5%)
52
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
11
Within 1 year
0
After 2+ years
313
Days since retraction (latest)
Strategic Application of Bio-reductive Metalloprodrugs for Cancer Cell-Selective Anticancer Therapy
Moubani Mukherjee, Bude Venkataswamy, Maynak Pal et al. (4 authors)
Unknown Journal
Published: Jan 2025
313 days after retraction
Metal-based immunogenic cell death inducers for cancer immunotherapy
Jun Zou, Meng Rui Chang, Nikita A. Kuznetsov et al. (6 authors)
Chemical Science
Open Access
Published: Jan 2025
313 days after retraction
Platinum‐Metformin Conjugates Acting as Promising PD‐L1 Inhibitors through the AMP‐Activated Protein Kinase Mediated Lysosomal Degradation Pathway
Bin Liu, Bing‐Bing Liang, Wan-Di Cao et al. (6 authors)
Angewandte Chemie International Edition
Open Access
Published: Aug 2024
3 citations
3 citations
188 days after retraction
Platinum‐Metformin Conjugates Acting as Promising PD‐L1 Inhibitors through the AMP‐Activated Protein Kinase Mediated Lysosomal Degradation Pathway
Bin Liu, Bing‐Bing Liang, Wan-Di Cao et al. (6 authors)
Angewandte Chemie
Published: Aug 2024
1 citation
1 citation
188 days after retraction
Targeting the epigenome with advanced delivery strategies for epigenetic modulators
Sonia Guha, Yogeswaran Jagadeesan, Murali Monohar Pandey et al. (5 authors)
Bioengineering & Translational Medicine
Open Access
Published: Aug 2024
5 citations
5 citations
176 days after retraction
Rhodium(III) Complex Noncanonically Potentiates Antitumor Immune Responses by Inhibiting Wnt/β-Catenin Signaling
Feng-Yang Wang, Liang-Mei Yang, Xiaolin Xiong et al. (12 authors)
Journal of Medicinal Chemistry
Published: Aug 2024
4 citations
4 citations
171 days after retraction
Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis
Lu Yuan, Shanshan Wang, Mengya Li et al. (9 authors)
Acta Pharmaceutica Sinica B
Open Access
Published: Jun 2024
13 citations
13 citations
123 days after retraction
Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis
Ke-Bin Huang, Feng-Yang Wang, Yuan Lu et al. (11 authors)
Proceedings of the National Academy of Sciences
Published: Jun 2024
16 citations
16 citations
102 days after retraction
Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy
Peng Xie, Qiao Jin, Lingpu Zhang et al. (10 authors)
ACS Nano
Published: May 2024
10 citations
10 citations
82 days after retraction
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
Le Tu, Chonglu Li, Qihang Ding et al. (8 authors)
Journal of the American Chemical Society
Published: Mar 2024
56 citations
56 citations
27 days after retraction
Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity
Sainath Babaji Aher, J. Zhu, Pundlik Rambhau Bhagat et al. (5 authors)
Topics in Current Chemistry
Published: Feb 2024
8 citations
8 citations
1 days after retraction
Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial–Mesenchymal Transition and Arousing Immune Response
Ming Zhang, Yan Chen, Zhifang Liu et al. (5 authors)
Journal of Medicinal Chemistry
Published: Jan 2024
15 citations
15 citations
37 days before retraction
Development of Platinum Complexes for Tumor Chemoimmunotherapy
S. Jin, Yan Guo, Xiaoyong Wang
Chemistry - A European Journal
Published: Jan 2024
18 citations
18 citations
51 days before retraction
Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
Pavel Štarha, Radka Křikavová
Coordination Chemistry Reviews
Published: Dec 2023
28 citations
28 citations
74 days before retraction
Chiral SPINOL-Based Pt(II) Metallacycles For Immunogenic Cell Death
Lu Zhu, Wenjing Du, Yanrong Li et al. (7 authors)
Inorganic Chemistry
Published: Sep 2023
10 citations
10 citations
170 days before retraction
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death
Amrita Sarkar, Vojtěch Novohradský, Moumita Maji et al. (10 authors)
Angewandte Chemie International Edition
Open Access
Published: Aug 2023
27 citations
27 citations
177 days before retraction
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death
Amrita Sarkar, Vojtěch Novohradský, Moumita Maji et al. (10 authors)
Angewandte Chemie
Open Access
Published: Aug 2023
177 days before retraction
Potent Zinc(II)-Based Immunogenic Cell Death Inducer Triggered by ROS-Mediated ERS and Mitochondrial Ca<sup>2+</sup> Overload
Lan-Shan Liao, Yin Chen, Cheng Hou et al. (7 authors)
Journal of Medicinal Chemistry
Published: Jul 2023
21 citations
21 citations
211 days before retraction
Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy
Sihui Yu, Hongyang Xiao, Li Ma et al. (5 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Jun 2023
29 citations
29 citations
240 days before retraction
Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma
Zhibin Yang, Mianli Bian, Lin Lv et al. (8 authors)
Journal of Medicinal Chemistry
Published: Feb 2023
41 citations
41 citations
364 days before retraction
Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents
Ming Zhang, Linming Li, Suying Li et al. (10 authors)
Journal of Medicinal Chemistry
Published: Feb 2023
32 citations
32 citations
366 days before retraction
Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy
Lingpu Zhang, Nicolás Montesdeoca, Johannes Karges et al. (4 authors)
Angewandte Chemie International Edition
Open Access
Published: Feb 2023
131 citations
131 citations
367 days before retraction
Immunogenen Zelltod induzierende Metallkomplexe für die Krebstherapie
Lingpu Zhang, Nicolás Montesdeoca, Johannes Karges et al. (4 authors)
Angewandte Chemie
Open Access
Published: Feb 2023
3 citations
3 citations
367 days before retraction
<i>In situ</i>oxidative polymerization of platinum(<scp>iv</scp>) prodrugs in pore-confined spaces of CaCO<sub>3</sub>nanoparticles for cancer chemoimmunotherapy
Fangmian Wei, Libing Ke, Siyuan Gao et al. (8 authors)
Chemical Science
Open Access
Published: Jan 2023
17 citations
17 citations
418 days before retraction
Platinum(<scp>iv</scp>) combo prodrugs containing cyclohexane-1<i>R</i>,2<i>R</i>-diamine, valproic acid, and perillic acid as a multiaction chemotherapeutic platform for colon cancer
Elisabetta Gabano, Marzia Bruna Gariboldi, Emanuela Marras et al. (5 authors)
Dalton Transactions
Open Access
Published: Jan 2023
3 citations
3 citations
418 days before retraction
Disruption of Zinc Homeostasis by a Novel Platinum(IV)‐Terthiophene Complex for Antitumor Immunity
Xuxian Su, Bin Liu, Wenjin Wang et al. (8 authors)
Angewandte Chemie International Edition
Published: Dec 2022
53 citations
53 citations
428 days before retraction
Disruption of Zinc Homeostasis by a Novel Platinum(IV)‐Terthiophene Complex for Antitumor Immunity
Xuxian Su, Bin Liu, Wenjin Wang et al. (8 authors)
Angewandte Chemie
Published: Dec 2022
5 citations
5 citations
428 days before retraction
Towards Understanding the Molecular Mechanisms of Immunogenic Cell Death
Xiaolin Xiong, Yuan Wang, Taotao Zou
ChemBioChem
Open Access
Published: Nov 2022
7 citations
7 citations
451 days before retraction
Berplatin: A Conjugate of Berberine and Cisplatin Serving as a Potent Antitumor Agent with Distinctive Tumor Cell Uptake and Minimal Side Effects
Beibei Xu, Xiangjie Luo, Jing Xiong et al. (14 authors)
Advanced Therapeutics
Published: Nov 2022
462 days before retraction
Induction of immunogenic cell death by novel platinum-based anticancer agents
Xingyu Chang, Mianli Bian, Lijuan Liu et al. (8 authors)
Pharmacological Research
Open Access
Published: Nov 2022
42 citations
42 citations
463 days before retraction
Design and biological features of platinum (II) complexes with 3-hydroxy-3-(Trifluoromethyl)cyclobutane-1,1-Dicarboxylate as a leaving ligand
Fengfan Liu, Yang Chen, Shaoguang Li et al. (10 authors)
European Journal of Medicinal Chemistry
Published: Aug 2022
9 citations
9 citations
555 days before retraction
Microwave-Assisted Synthesis: Can Transition Metal Complexes Take Advantage of This “Green” Method?
Elisabetta Gabano, Mauro Ravera
Molecules
Open Access
Published: Jun 2022
38 citations
38 citations
603 days before retraction
Target Profiling of an Iridium(III)-Based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP
Xiaolin Xiong, Ke-Bin Huang, Yuan Wang et al. (12 authors)
Journal of the American Chemical Society
Published: Jun 2022
64 citations
64 citations
630 days before retraction
Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy
Zhiyuan Li, Qing‐Hua Shen, Zong‐Wan Mao et al. (4 authors)
Chemistry - An Asian Journal
Published: Apr 2022
24 citations
24 citations
680 days before retraction
BQ-AurIPr: A Redox-Active Anticancer Au(I) Complex that Induces Immunogenic Cell Death in Non-Small Cell Lung Cancer
Ravindra D. Mule, Akhilesh Kumar, Shashank P. Sancheti et al. (6 authors)
Unknown Journal
Open Access
Published: Mar 2022
707 days before retraction
Metal complexes as chemotherapeutic agents
Krishant M. Deo, Janice R. Aldrich‐Wright
Elsevier eBooks
Published: Feb 2022
727 days before retraction
An 8-hydroxyquinoline-N-oxide manganese(II) complex induces apoptosis of A549/DDP cells by disrupting the mitochondrial pathway
Chengming Wang, Zhen Zhou, Hui-Si Cao et al. (5 authors)
Inorganic Chemistry Communications
Published: Jan 2022
3 citations
3 citations
760 days before retraction
Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma
Mianli Bian, Rong Fan, Zhibin Yang et al. (7 authors)
Journal of Medicinal Chemistry
Published: Jan 2022
65 citations
65 citations
771 days before retraction
Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future
Sajal Sen, Miae Won, Matthew S. Levine et al. (8 authors)
Chemical Society Reviews
Open Access
Published: Jan 2022
197 citations
197 citations
783 days before retraction
BQ-AurIPr: a redox-active anticancer Au(<scp>i</scp>) complex that induces immunogenic cell death
Ravindra D. Mule, Akhilesh Kumar, Shashank P. Sancheti et al. (6 authors)
Chemical Science
Open Access
Published: Jan 2022
20 citations
20 citations
783 days before retraction
Pt(<scp>iv</scp>) antitumor prodrugs: dogmas, paradigms, and realities
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey et al. (4 authors)
Dalton Transactions
Published: Dec 2021
50 citations
50 citations
788 days before retraction
Highly Efficient Ir(III)‐Coumarin Photo‐Redox Catalyst for Synergetic Multi‐Mode Cancer Photo‐Therapy
Zhongxian Fan, Jiaen Xie, Tumpa Sadhukhan et al. (11 authors)
Chemistry - A European Journal
Published: Nov 2021
25 citations
25 citations
835 days before retraction
Breakdown of chemo-immune resistance by a TDO2-targeted Pt(IV) prodrug via attenuating endogenous Kyn-AhR-AQP4 metabolic circuity and TLS-promoted genomic instability
Feihong Chen, Gang Xu, Wenyuan Tian et al. (4 authors)
Biochemical Pharmacology
Published: Sep 2021
7 citations
7 citations
884 days before retraction
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu et al. (4 authors)
Coordination Chemistry Reviews
Published: Sep 2021
126 citations
126 citations
892 days before retraction
Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy
Mengjiao Zhou, Minjian Yuan, Meng Zhang et al. (7 authors)
European Journal of Medicinal Chemistry
Open Access
Published: Sep 2021
62 citations
62 citations
902 days before retraction
A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma
Béatrice Ferrari, E. Roda, Erica Cecilia Priori et al. (10 authors)
Frontiers in Neuroscience
Open Access
Published: Mar 2021
17 citations
17 citations
1068 days before retraction
Monofunctional Platinum(II) Anticancer Agents
S. Jin, Yan Guo, Zijian Guo et al. (4 authors)
Pharmaceuticals
Open Access
Published: Feb 2021
58 citations
58 citations
1111 days before retraction
Pt(<scp>iv</scp>) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity
Elisabetta Gabano, Beatrice Rangone, Elena Perin et al. (11 authors)
Dalton Transactions
Published: Jan 2021
11 citations
11 citations
1148 days before retraction
Synthesis, structures and anticancer potentials of five platinum(II) complexes with benzothiazole-benzopyran targeting mitochondria
Qing-Min Wei, Zu‐Zhuang Wei, Jia-Jing Zeng et al. (7 authors)
Polyhedron
Published: Dec 2020
10 citations
10 citations
1154 days before retraction
Immunogenicity and cytotoxicity of a platinum(<scp>iv</scp>) complex derived from capsaicin
Yuewen Sun, Enmao Yin, Yehong Tan et al. (8 authors)
Dalton Transactions
Published: Dec 2020
36 citations
36 citations
1165 days before retraction
Quick Stats
Total Citations:
63
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025